U.S. Physical Therapy, Inc.
Thesis
U.S. Physical Therapy is poised to benefit from secular demand growth for physical therapy services, with attractive unit economics and solid cash flow. The company has opportunities for market share growth through targeted advertising, partnerships, and acquisitions in a fragmented market. At 12.6x LTM adjusted free cash flow, it is attractively valued, with a target price of $24.00 per share, representing a 33% upside.
Did it work?
The pitch is a valuation-driven long thesis with a $24.00 target (33% upside), but neither the time elapsed nor the price performance since the pitch is available, so the return cannot be weighed against the stated direction or target. There is also no information on whether the thesis's supporting events — market share gains, acquisitions, or sustained cash flow generation — actually occurred. Without price data or confirmation of thesis catalysts, the outcome cannot be judged.